(6S,9S,12S,15S,18S,21S,24S,27S,30S,33S,36S,39S,42S,45S,48S,51S,54S,57S,63S)-15,54-bis((1H-indol-3-yl)methyl)-1,63-diamino-21,51-bis(4-aminobutyl)-12,33,42-tribenzyl-57-((S)-sec-butyl)-6-carbamoyl-9,18-bis(4-hydroxybenzyl)-24,30,36,39-tetrakis((R)-1-hydroxyethyl)-45-(hydroxymethyl)-1-imino-27-isopropyl-48-methyl-8,11,14,17,20,23,26,29,32,35,38,41,44,47,50,53,56,59,62-nonadecaoxo-2,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52,55,58,61-icosaazapentahexacontan-65-oic acid

Catalog No. :
ACVJQW002
CAS No. :
2757108-69-1
Molecular Formula :
C124H170N28O29
Molecular Weight :
2516.89

IUPAC Name:(6S,9S,12S,15S,18S,21S,24S,27S,30S,33S,36S,39S,42S,45S,48S,51S,54S,57S,63S)-15,54-bis((1H-indol-3-yl)methyl)-1,63-diamino-21,51-bis(4-aminobutyl)-12,33,42-tribenzyl-57-((S)-sec-butyl)-6-carbamoyl-9,18-bis(4-hydroxybenzyl)-24,30,36,39-tetrakis((R)-1-hydroxyethyl)-45-(hydroxymethyl)-1-imino-27-isopropyl-48-methyl-8,11,14,17,20,23,26,29,32,35,38,41,44,47,50,53,56,59,62-nonadecaoxo-2,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52,55,58,61-icosaazapentahexacontan-65-oic acid

(6S,9S,12S,15S,18S,21S,24S,27S,30S,33S,36S,39S,42S,45S,48S,51S,54S,57S,63S)-15,54-bis((1H-indol-3-yl)methyl)-1,63-diamino-21,51-bis(4-aminobutyl)-12,33,42-tribenzyl-57-((S)-sec-butyl)-6-carbamoyl-9,18-bis(4-hydroxybenzyl)-24,30,36,39-tetrakis((R)-1-hydroxyethyl)-45-(hydroxymethyl)-1-imino-27-isopropyl-48-methyl-8,11,14,17,20,23,26,29,32,35,38,41,44,47,50,53,56,59,62-nonadecaoxo-2,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52,55,58,61-icosaazapentahexacontan-65-oic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(6S,9S,12S,15S,18S,21S,24S,27S,30S,33S,36S,39S,42S,45S,48S,51S,54S,57S,63S)-15,54-bis((1H-indol-3-yl)methyl)-1,63-diamino-21,51-bis(4-aminobutyl)-12,33,42-tribenzyl-57-((S)-sec-butyl)-6-carbamoyl-9,18-bis(4-hydroxybenzyl)-24,30,36,39-tetrakis((R)-1-hydroxyethyl)-45-(hydroxymethyl)-1-imino-27-isopropyl-48-methyl-8,11,14,17,20,23,26,29,32,35,38,41,44,47,50,53,56,59,62-nonadecaoxo-2,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52,55,58,61-icosaazapentahexacontan-65-oic acid
IUPAC Name(6S,9S,12S,15S,18S,21S,24S,27S,30S,33S,36S,39S,42S,45S,48S,51S,54S,57S,63S)-15,54-bis((1H-indol-3-yl)methyl)-1,63-diamino-21,51-bis(4-aminobutyl)-12,33,42-tribenzyl-57-((S)-sec-butyl)-6-carbamoyl-9,18-bis(4-hydroxybenzyl)-24,30,36,39-tetrakis((R)-1-hydroxyethyl)-45-(hydroxymethyl)-1-imino-27-isopropyl-48-methyl-8,11,14,17,20,23,26,29,32,35,38,41,44,47,50,53,56,59,62-nonadecaoxo-2,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52,55,58,61-icosaazapentahexacontan-65-oic acid
Molecular FormulaC124H170N28O29
Molecular Weight2516.89
SMILESCC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O
InChI KeyPAVWQTOVNBSRNJ-VFRNGJKNSA-N
SynonymCaveolin-1 (82-101) amide (human, mouse, rat)
CAS No.2757108-69-1

Synthetic Route by SureRoute

1. ACVJQW002 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVJQW002 route product structure diagram
    ACVJQW0022757108-69-1
Inquiry

2. ACVJQW002 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVJQW002 route product structure diagram
    ACVJQW0022757108-69-1
Inquiry

Comments (0)